Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Naltrexone Treatment of Alcohol Abuse in Schizophrenia

NCT00145847 is registered in ClinicalTrials.gov with State University of New York - Upstate Medical University as lead sponsor.

NCT NCT00145847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00145847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Naltrexone Treatment of Alcohol Abuse in Schizophrenia
Lead sponsor
State University of New York - Upstate Medical University
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2003
Completion date
May 31, 2008
Enrollment
90 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol abuse, alcohol-related disorders, alcoholism, mental disorders, schizophrenia